Daily News Podcast

Statin effect in prostate cancer may be caused by reduced inflammation


 

Long-term use of statins may protect against lethal forms of prostate cancer by altering the inflammatory profile of the tumor microenvironment. Also today, Verma unveils Medicaid scorecard but refuses to judge efforts, the AMA reports that opioid prescriptions are down since 2013, and a prior knee injury creates a ‘distinct group’ in osteoarthritis.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Sarcopenia had minor impact on hernia repair SSIs
MDedge Hematology and Oncology
MDedge Daily News: Group support, mentorship help combat burnout in female physicians
MDedge Hematology and Oncology
Psoriasis therapy with biologics not linked to increased cancer risk
MDedge Hematology and Oncology
High testosterone in postmenopausal women may add CVD risk
MDedge Hematology and Oncology
Severity of sepsis-associated coagulopathy predicts hospital mortality
MDedge Hematology and Oncology
ACS: Screen for colon cancer at 45
MDedge Hematology and Oncology
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
MDedge Hematology and Oncology
What is causing my patients’ macrocytosis?
MDedge Hematology and Oncology
Hip pain predicts arthritis mortality beyond comorbidities
MDedge Hematology and Oncology
Prostate cancer risk before age 55 higher for black men
MDedge Hematology and Oncology